Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis.
about
Familial adenomatous polyposisNSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinomaAspirin in the Chemoprevention of Colorectal Neoplasia: An OverviewNon steroidal anti-inflammatory drugs (NSAID) and aspirin for preventing colorectal adenomas and carcinomasThe 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-delta to induce apoptosis in colorectal cancer cells15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancersColorectal cancer chemoprevention: is this the future of colorectal cancer prevention?Inherited colorectal cancer syndromesCombination oral antiangiogenic therapy with thalidomide and sulindac inhibits tumour growth in rabbitsModulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acidsLung cancer. 1: prevention of lung cancerSulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cellsIn vitro and in vivo evaluation of NCX 4040 cytotoxic activity in human colon cancer cell linesSulindac derivatives inhibit cell growth and induce apoptosis in primary cells from malignant peripheral nerve sheath tumors of NF1-patientsTherapeutic utility of aspirin in the ApcMin/+ murine model of colon carcinogenesis.Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligandsMolecular cancer prevention: Current status and future directionsDuodenal adenoma surveillance in patients with familial adenomatous polyposisTargeting the Wnt pathway in human cancers: therapeutic targeting with a focus on OMP-54F28Anti-tumor activity of non-steroidal anti-inflammatory drugs: cyclooxygenase-independent targetsChemoprevention in familial adenomatous polyposisEffect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous Polyposis: A Randomized Clinical Trial.Role of Urinary Biomarkers in the Diagnosis of Adenoma and Colorectal Cancer: A Systematic Review and Meta-AnalysisEffects of supplemental vitamin D and calcium on normal colon tissue and circulating biomarkers of risk for colorectal neoplasmsThe evolving role of nonsteroidal anti-inflammatory drugs in colon cancer prevention: a cause for optimismUse of NSAIDs for the chemoprevention of colorectal cancerSulindac targets nuclear beta-catenin accumulation and Wnt signalling in adenomas of patients with familial adenomatous polyposis and in human colorectal cancer cell linesPrimary and secondary prevention in colorectal cancerIncreased expression of cyclooxygenase-2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitorsAspirin induces apoptosis through release of cytochrome c from mitochondriaAspirin and risk for gastric cancer: a population-based case-control study in SwedenInhibition of store-operated calcium entry contributes to the anti-proliferative effect of non-steroidal anti-inflammatory drugs in human colon cancer cellsFamiliar drugs may prevent cancerPotential use of COX-2-aromatase inhibitor combinations in breast cancerCOX-2 and cancer: a new approach to an old problemCancer chemoprevention: lessons learned and future directionsCelecoxib as adjunctive therapy for treatment of colorectal cancerChemoprevention of colorectal cancerNon-steroidal anti-inflammatory drugs (NSAIDs) inhibit vascular smooth muscle cell proliferation via differential effects on the cell cyclePronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene
P2860
Q21202887-82A636F7-BD94-4180-A19C-2AEBE01FEE26Q21563424-6229FF88-8325-45DA-A316-875CAFBBDC3AQ22306433-476ED025-E1BD-462E-8339-AAB57B7470EFQ24247367-8DFF6524-BBC9-4E3E-B90C-BE0221A3EE75Q24314509-CCA7576A-7A07-40B0-999B-C548E6044021Q24318523-701AF65D-F612-4728-9858-59C851CBFB50Q24620457-5E7F543B-BA25-4F1D-893D-F32AE69EB4A2Q24628009-CCA5424C-E601-41A5-90E0-507C901FE81DQ24650329-ED235803-AD05-4F8C-AA75-90127F1D9E29Q24674656-99D295CD-06EC-4E95-ADC1-14B864A1CBF7Q24678926-3886C6E5-81ED-41DD-BC75-7A69AC7EC1CAQ24683705-568FE6C6-2606-4AF2-B39F-F2FDE1B676F9Q24792522-11538E10-01F8-4207-8AF9-7BBBAC064C95Q24794243-E19BCAAA-566D-42A3-8576-DF446D3FA66CQ24799697-07AE250F-2F56-4F69-AD34-C21C707C2959Q24810709-23D72ED1-1984-499C-A964-D168A1BFF091Q26797207-A4D1F7B5-01F5-4E4C-BB7E-A01F0ADD9F3CQ26799039-BB88B4A4-919B-4EFF-99C4-9BE335A4E77FQ26991723-C1ADCACF-65B0-461F-BD11-26F483BF4572Q27004250-6F0480FB-D6D0-42D2-B9AC-93855870AEB0Q27023845-AD9359C9-E525-4D40-99AF-B0CA56B5116FQ27347642-2A30085B-48BA-4A81-9C46-C0084DA33B57Q28067664-05989F60-B72C-488F-A277-3933B79C84D6Q28083343-4CC27CB3-7E3C-46C5-805F-BC73B9257728Q28087427-145EC25F-10C7-485F-8CDD-4AF14A444183Q28165741-F7A55931-DB91-4117-AE77-266EE8E3E66EQ28166679-3368B0C6-FCD3-454E-B175-296CCEB00F82Q28167290-B4BBC88F-8503-432D-BBD9-B2360F571EC5Q28175922-A16A4147-5E77-4632-B010-FEEC05240A9BQ28176509-9E3CAC8F-765C-4CB2-9765-A751585DEE91Q28181380-AB591E46-B154-4FB1-AD04-DA8C81CEB7B2Q28183525-936C7781-8804-461F-86AB-1616A49F4DE4Q28186835-0F774D6E-47D0-4306-A837-EE0323A12F4BQ28187414-F66E5E6F-9F91-43E7-A4F8-E5BF571CEB01Q28191533-7679CEB2-3A09-44B0-946D-4CBA24461908Q28191856-3317DB94-B22C-40E7-AE12-CE29803EF2A1Q28192119-39707B32-B42E-497A-BDA5-763571073ED8Q28192222-8B2EB4F8-296F-4866-A8CB-E7F9802908BAQ28196440-ED1719A0-82BC-4CF1-B6B6-5C542D2260B3Q28196474-676DD1D0-9D7C-40D0-B3A8-C6B321487F27
P2860
Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis.
description
1993 nî lūn-bûn
@nan
1993 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis.
@ast
Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis.
@en
Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis.
@nl
type
label
Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis.
@ast
Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis.
@en
Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis.
@nl
prefLabel
Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis.
@ast
Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis.
@en
Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis.
@nl
P2093
P1476
Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis.
@en
P2093
Giardiello FM
Hamilton SR
Offerhaus GJ
Piantadosi S
Robinson CR
P304
P356
10.1056/NEJM199305063281805
P407
P577
1993-05-01T00:00:00Z